Lafarge Boral Plasterboard JV in Asia Invests in Vietnam

Lafarge Boral Gypsum Vietnam (LBGV), a wholly owned subsidiary of the 50/50 joint venture Lafarge Boral Gypsum in Asia Limited (LBGA), advises construction of a plasterboard plant in the Ho Chi Minh City area of Vietnam has commenced. This plant will be the first plasterboard plant to be built and operated in Vietnam.

LBGV was granted a business license to build and operate this plant in May 2005 and recently acquired an appropriate site. Plasterboard production capacity is expected to be 10 million m² per annum initially and the site allows flexibility to increase capacity in the future. The total investment, including land, is expected to be around US$13 million and the new plant is expected to be in operation during 2006.

LBGA has established a leadership position in the Vietnam plasterboard market over the last four years through the import of plasterboard products and systems. During that time the market has developed rapidly and plasterboard systems are now more widely known and used in Vietnam. As a result, LBGV is now able to invest in domestic manufacturing capacity and so provide better service and more flexibility to its customers.

Lafarge, the world leader in building materials, holds top-ranking positions in all four of its Divisions: Cement, Aggregates and Concrete, Roofing and Gypsum. Lafarge employs 77 000 people in 75 countries and posted sales of € 14.4 billon in 2004. Lafarge, which first moved into Vietnam in 2001, is currently building a cement grinding plant on the Long Tau river, 20km south-east of Ho Chi Minh City in Dong Nai province, which is set to be operational early next year.

http://www.boral.com.au

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.